BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 23632816)

  • 1. Age-specific occurrence of HPV16- and HPV18-related cervical cancer.
    de Sanjose S; Wheeler CM; Quint WGV; Hunt WC; Joste NE; Alemany L; Bosch FX; ; Myers ER; Castle PE
    Cancer Epidemiol Biomarkers Prev; 2013 Jul; 22(7):1313-1318. PubMed ID: 23632816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States.
    Wheeler CM; Hunt WC; Joste NE; Key CR; Quint WG; Castle PE
    J Natl Cancer Inst; 2009 Apr; 101(7):475-87. PubMed ID: 19318628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa.
    Clifford GM; de Vuyst H; Tenet V; Plummer M; Tully S; Franceschi S
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):332-339. PubMed ID: 27331659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of cervical screening by human papillomavirus genotype: Population-based estimations.
    Wang J; Elfström KM; Lagheden C; Eklund C; Sundström K; Sparén P; Dillner J
    PLoS Med; 2023 Oct; 20(10):e1004304. PubMed ID: 37889928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    de Martel C; Plummer M; Vignat J; Franceschi S
    Int J Cancer; 2017 Aug; 141(4):664-670. PubMed ID: 28369882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active women.
    Ng K; Morais S; Wissing MD; Burchell AN; Tellier P-P; Coutlée F; Waterboer T; El-Zein M; Franco EL
    Microbiol Spectr; 2024 Jun; 12(6):e0022924. PubMed ID: 38687066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: Whole viral genome sequences from 7116 HPV16-positive women.
    Clifford GM; Tenet V; Georges D; Alemany L; Pavón MA; Chen Z; Yeager M; Cullen M; Boland JF; Bass S; Steinberg M; Raine-Bennett T; Lorey T; Wentzensen N; Walker J; Zuna R; Schiffman M; Mirabello L
    Papillomavirus Res; 2019 Jun; 7():67-74. PubMed ID: 30738204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of human papillomavirus 16 variants and risk for cervical cancer in Chinese population.
    Hang D; Yin Y; Han J; Jiang J; Ma H; Xie S; Feng X; Zhang K; Hu Z; Shen H; Clifford GM; Dai M; Li N
    Virology; 2016 Jan; 488():156-61. PubMed ID: 26650690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of HPV vaccination on HPV-related oral infections.
    Gheit T; Muwonge R; Lucas E; Galati L; Anantharaman D; McKay-Chopin S; Malvi SG; Jayant K; Joshi S; Esmy PO; Pillai MR; Basu P; Sankaranarayanan R; Tommasino M
    Oral Oncol; 2023 Jan; 136():106244. PubMed ID: 36402055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus vaccine impact on invasive cervical cancer in Japan: Preliminary results from cancer statistics and the MINT study.
    Onuki M; Takahashi F; Iwata T; Nakazawa H; Yahata H; Kanao H; Horie K; Konnai K; Nio A; Takehara K; Kamiura S; Tsuda N; Takei Y; Shigeta S; Matsumura N; Yoshida H; Motohara T; Yamazaki H; Nakamura K; Hamanishi J; Tasaka N; Ishikawa M; Hirashima Y; Kudaka W; Mori-Uchino M; Kukimoto I; Fujii T; Watanabe Y; Noda K; Yoshikawa H; Yaegashi N; Matsumoto K;
    Cancer Sci; 2023 Nov; 114(11):4426-4432. PubMed ID: 37688310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of two genomic variants with HPV type-specific risk of cervical cancer.
    Seifert F; Eisenblätter R; Beckmann J; Schürmann P; Hanel P; Jentschke M; Böhmer G; Strauß HG; Hirchenhain C; Schmidmayr M; Müller F; Fasching P; Luyten A; Häfner N; Dürst M; Runnebaum IB; Hillemanns P; Dörk T; Ramachandran D
    Tumour Virus Res; 2023 Dec; 16():200269. PubMed ID: 37499979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type-specific human papillomavirus biological features: validated model-based estimates.
    Baussano I; Elfström KM; Lazzarato F; Gillio-Tos A; De Marco L; Carozzi F; Del Mistro A; Dillner J; Franceschi S; Ronco G
    PLoS One; 2013; 8(11):e81171. PubMed ID: 24400036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-γ-induced GBP1 is an inhibitor of human papillomavirus 18.
    Xu M; Lin MC; Li ZH
    BMC Womens Health; 2024 Apr; 24(1):240. PubMed ID: 38622605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid immunoassay for dual-mode detection of HPV16 and HPV18 DNA based on Au@PdPt nanoparticles.
    Xiao H; Chen W; Lin M; Jiang S; Cui X; Zhao S
    Anal Methods; 2024 Mar; 16(13):1862-1869. PubMed ID: 38463013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple HPV integration mode in the cell lines based on long-reads sequencing.
    Cui X; Li Y; Zhang C; Qi Y; Sun Y; Li W
    Front Microbiol; 2023; 14():1294146. PubMed ID: 38169727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis.
    Drolet M; Bénard É; Boily MC; Ali H; Baandrup L; Bauer H; Beddows S; Brisson J; Brotherton JM; Cummings T; Donovan B; Fairley CK; Flagg EW; Johnson AM; Kahn JA; Kavanagh K; Kjaer SK; Kliewer EV; Lemieux-Mellouki P; Markowitz L; Mboup A; Mesher D; Niccolai L; Oliphant J; Pollock KG; Soldan K; Sonnenberg P; Tabrizi SN; Tanton C; Brisson M
    Lancet Infect Dis; 2015 May; 15(5):565-80. PubMed ID: 25744474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study.
    Liu XX; Fan XL; Yu YP; Ji L; Yan J; Sun AH
    BMC Infect Dis; 2014 Dec; 14():708. PubMed ID: 25523884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictable changes in the accuracy of human papillomavirus tests after vaccination: review with implications for performance monitoring in cervical screening.
    Rebolj M; Brentnall AR; Cuschieri K
    Br J Cancer; 2024 May; 130(11):1733-1743. PubMed ID: 38615108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of age‑specific distribution of combination patterns of cytology and high‑risk HPV status on cervical intraepithelial neoplasia grade 2 or more.
    Sakai M; Ohara T; Suzuki H; Kadomoto T; Inayama Y; Shitanaka S; Sumitomo M; Matsumura N; Yamanoi K
    Oncol Lett; 2023 Sep; 26(3):384. PubMed ID: 37559589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of human papillomavirus genotypes by severity of cervical lesions in HPV screened positive women from the ESTAMPA study in Latin America.
    Correa RM; Baena A; Valls J; Colucci MC; Mendoza L; Rol M; Wiesner C; Ferrera A; Fellner MD; González JV; Basiletti JA; Mongelos P; Rodriguez de la Peña M; Saino A; Kasamatsu E; Velarde C; Macavilca N; Martinez S; Venegas G; Calderón A; Rodriguez G; Barrios H; Herrero R; Almonte M; Picconi MA;
    PLoS One; 2022; 17(7):e0272205. PubMed ID: 35905130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.